Flexeril and Add - a phase IV clinical study of FDA data

Summary:

Add is reported as a side effect among people who take Flexeril (cyclobenzaprine hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Cymbalta, and have Pain.

The phase IV clinical study analyzes which people have Add when taking Flexeril. It is created by eHealthMe based on reports of 34,789 people who have side effects when taking Flexeril from the FDA, and is updated regularly.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,304 Flexeril users. Check the latest studies of Flexeril.

What is Add?

Add (attention deficit disorder-difficult to define) is found to be associated with 807 drugs and 1,367 conditions by eHealthMe. Check the latest studies of Add.

On Oct, 12, 2025

34,789 people reported to have side effects when taking Flexeril.
Among them, 9 people (0.03%) have Add.

Among these 9 people:

How long have people been on Flexeril when they have Add? *

What is the gender of people who have Add when taking Flexeril? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Add when taking Flexeril? *

What are other drugs people take besides Flexeril? *

What are other side effects people have besides Add? *

Bipolar Disorder (mood disorder): 4 people, 44.44%
Stress And Anxiety: 3 people, 33.33%
Depression: 3 people, 33.33%
Pain: 2 people, 22.22%
Weight Increased: 2 people, 22.22%
Hallucinations (sensations that appear real but are created by your mind): 2 people, 22.22%
Joint Pain: 2 people, 22.22%
Diabetes Mellitus Inadequate Control: 1 person, 11.11%
Disturbance In Attention: 1 person, 11.11%
Drug Dependence: 1 person, 11.11%

What are the existing conditions these people have? *

Pain: 3 people, 33.33%
Depression: 2 people, 22.22%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 22.22%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 11.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 11.11%
Asthma: 1 person, 11.11%
Bipolar Disorder (mood disorder): 1 person, 11.11%
Birth Control: 1 person, 11.11%
Erection Problems: 1 person, 11.11%
Gastric Ph Decreased: 1 person, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Flexeril and have Add?

- Check whether Add is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flexeril:

Flexeril (38,304 reports)

Add treatments and more:

Add (120,228 reports)

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Add:

Add (807 drugs)

Browse all the conditions that are associated with Add:

Add (1,367 conditions)

Drugs similar to Flexeril and Add :

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride (the active ingredients of Flexeril) and Flexeril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.